🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Immune therapies work with the body's immune system to treat a number of ca...
Status
Terminated
Location
Providence Medical Foundation
Start Date
2021-10-19
Trial ID
NCT05083481
This trial will evaluate the combination of modified infusional 5-fluoroura...
Status
Completed
Location
Oncology Hematology Associates of SW Indiana
Start Date
2005-07
Trial ID
NCT00193219
Treatments Being Tested
In this phase 2 study, the efficacy of total neoadjuvant therapy in Taiwane...
Status
Recruiting
Location
National Cheng Kung University Hospital
Start Date
2023-11-16
Trial ID
NCT06162650
Treatments Being Tested
This will be a randomized, open-label, multicenter, Phase II study with pri...
Status
Completed
Location
Multiple Locations
Start Date
2011-08
Trial ID
NCT01374425
Treatments Being Tested
Oxaliplatin-induced neuropathy is a major dose-limiting side effect in pati...
Status
Completed
Location
Washington University School of Medicine/Barnes Jewish Hospital
Start Date
2017-09-15
Trial ID
NCT03254394
Treatments Being Tested
A phase II, muti-cohort study to assess the efficacy and safety of Surufati...
Status
Unknown
Location
Multiple Locations
Start Date
2021-03
Trial ID
NCT04734249
Treatments Being Tested
The addition of durvalumab to total neoadjuvant therapy (TNT) in locally ad...
Status
Unknown
Location
Parc Taulí
Start Date
2019-12-18
Trial ID
NCT04293419
Treatments Being Tested
HARVEST is an investigator-initiated prospective randomized controlled stud...
Status
Terminated
Location
Sun Yat-sen University Cancer Center
Start Date
2018-05-28
Trial ID
NCT03500874
Treatments Being Tested
The purpose of this study: To explore the comparative effectiveness of BIB...
Status
Completed
Location
Universitätsklinikum Halle
Start Date
2011-06
Trial ID
NCT01362361
Treatments Being Tested
The goal of this open-label randomized, multicenter, comparative phase II t...
Status
Recruiting
Location
Institut de Cancérologie de l'Ouest
Start Date
2024-07-23
Trial ID
NCT06333314
Treatments Being Tested